1G·

Price war! The next nail in the coffin

For $NOVO B (-2,16%) . And I'm going to say $LLY (-1,63%) this will last longer. Further declining profit margins bring us closer to the assessment I made yesterday that there will be a dividend cut.

Novo Nordisk intensifies price war with Eli Lilly on weight-loss drugs

Novo Nordisk plans to raise US list prices for its popular weight-loss and diabetes drugs, Wegovy and Ozempicby up to half from next year, intensifying the price war with competitor Eli Lilly. The companies are competing on price, lowering net prices for popular GLP-1 weight-loss drugs through rebates to insurers and consumers, including recent agreements with the Trump administration. Both companies have also sought to make the drugs more accessible to potential customers by offering their drugs for sale directly through websites.

6 Commenti

Tenbagger2024@Tenbagger2024

Wait and see when the Swiss bring something else onto the market, then things will get even wilder. I already wrote that last year

•

David I.@dildefonso

@Tenbagger2024 which company ?

••

DocTrader@value_crafter_1628

I have already written a lot about weight loss drugs and Novo Nordisk in particular. As a doctor, I can only emphasize it once again: in contrast to the European market and especially in Germany, we have a completely different behavior of potential consumers in the USA. In the USA, people are prepared to pay for such drugs, whereas here in Europe and especially in Germany, patients are much more price-sensitive when it comes to their own contribution or even self-financing of such products. There is hardly any demand in Asia and Africa, so the whole thing will take place in the western world. It is clear that the winner's podium is set for Eli Lilly. Of course, you can also trade the shares of the second and third-placed companies from time to time, but if you want to bet on the winners, you're in the wrong place with Novo at the moment. Good luck 🍀

•

Felix K.@FelixKowal

Novo is garbage

••

Kris@Mit44inRente

16H

@FelixKowal The only thing that's garbage is your comment.

••

Chris@Multibagger

16H

@Mit44inRente 😉😎 I think it would have been better if he had written Pommesbude. 😉😎 That's where I see them in relation to the competition, both in terms of size, number of drugs and the most important point, management.

•